Northeast Financial Consultants’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-4,399
Closed -$779K 319
2020
Q1
$779K Sell
4,399
-1,736
-28% -$327K 0.09% 138
2019
Q4
$1.17M Sell
6,135
-146
-2% -$26.3K 0.1% 120
2019
Q3
$1.06M Hold
6,281
0.11% 128
2019
Q2
$1.05M Hold
6,281
0.11% 125
2019
Q1
$920K Buy
+6,281
New +$911K 0.1% 126
2018
Q3
Sell
-5,805
Closed -$967K 181
2018
Q2
$967K Hold
5,805
0.3% 49
2018
Q1
$976K Buy
5,805
+1,899
+49% +$319K 0.33% 47
2017
Q4
$638K Hold
3,906
0.21% 80
2017
Q3
$801K Hold
3,906
0.29% 56
2017
Q2
$950K Buy
3,906
+1,328
+52% +$312K 0.37% 53
2017
Q1
$616K Sell
2,578
-28
-1% -$6.52K 0.26% 69
2016
Q4
$547K Hold
2,606
0.24% 72
2016
Q3
$600K Buy
2,606
+146
+6% +$35.7K 0.25% 70
2016
Q2
$568K Sell
2,460
-1,345
-35% -$310K 0.25% 68
2016
Q1
$1.02M Hold
3,805
0.54% 36
2015
Q4
$1.19M Buy
3,805
+425
+13% +$127K 0.62% 33
2015
Q3
$919K Hold
3,380
0.47% 41
2015
Q2
$1.03M Buy
+3,380
New +$1.01M 0.46% 43

Other funds holding AGN

Northeast Financial Consultants's AGN Position: Q2 2020 in Review

Northeast Financial Consultants sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,399 shares — an estimated $779K sold.

Northeast Financial Consultants first reported a position in AGN in Q2 2015 and held it in 18 quarters. The position peaked at $1.19M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Northeast Financial Consultants reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Northeast Financial Consultants sold 4,399 Allergan plc shares in Q2 2020, an estimated $779K.
  • Northeast Financial Consultants first reported a position in Allergan plc in Q2 2015 and held it in 18 quarters.
  • Northeast Financial Consultants's Allergan plc position peaked at $1.19M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Northeast Financial Consultants's 13F filing for Q2 2020, filed 30 Jul 2020.